Paper Review Records
全部论文审稿周期
1 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
309
天
Anti–Receptor Activator of Nuclear Factor-κB Ligand Improves Muscle Dysfunction and Strengthens Bone in Laminin-α2–Deficient dy2J/dy2J Dystrophic Mice
作者
Zineb Bouredji; Anthony Facchin; Dounia Hamoudi; Hideo Yagita; Norbert Laroche; Marthe Rousseau; Anteneh Argaw; Jérôme Frenette展开收起
作者单位
1. Centre Hospitalier Universitaire de Québec–Université Laval Research Center, Axe Neurosciences, Université Laval, Quebec City, Quebec, Canada; 2. Department of Immunology, School of Medicine, Juntendo University, Tokyo, Japan; 3. Jean Monnet Université Saint-Étienne, INSERM, Mines Saint Étienne, Santé Ingénierie Biologie St-Étienne U1059, Saint-Étienne, France; 4. Unité Mixte de Recherche 5510 Matériaux Ingienrie et Science, Centre National de Recherche Scientifique/Lyon University/Institut National de Science Appliquée–Lyon, Lyon, France; 5. School of Rehabilitation Sciences, Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada展开收起
FAQ
AMERICAN JOURNAL OF PATHOLOGY审稿要多久?
截至2026-11-19,CrushSCI 只收录了 AMERICAN JOURNAL OF PATHOLOGY 的 1 篇完整审稿记录:Anti–Receptor Activator of Nuclear Factor-κB Ligand Improves Muscle Dysfunction and Strengthens Bone in Laminin-α2–Deficient dy2J/dy2J Dystrophic Mice,2025-06-11 收稿,2026-04-16 录用,审稿 309 天。只有一篇样本,结果仅供参考。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
